| Symbol | TRNHF |
|---|---|
| Name | TRANSCENTA HLDG. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | China Biobay B6-501, 218 Xinghu Street |
| Telephone | +86 21 6237 0929 |
| Fax | — |
| — | |
| Website | https://www.transcenta.com/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | — |
| Description | Transcenta Holding Ltd is a investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Companys products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company also provides contract development and manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research. Additional info from OTC: |
No news found.